کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1396636 | 1501196 | 2009 | 5 صفحه PDF | دانلود رایگان |

A new series of novel 5-(nitro/bromo)-styryl-2-benzimidazoles (1–12) has been synthesized by simple, mild and efficient synthetic protocol by attempted condensation of 5-(nitro/bromo)-o-phenylenediamine with trans-cinnamic acids in ethylene glycol. Screening for in vitro anti-tubercular activity against Mycobacterium tuberculosis H37 Rv, anti-bacterial activity against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Klebsiella pneumoniae bacterial strains and anti-fungal activity against Candida albicans and Asperigillus fumigatus fungal strains were carried out. Compounds 5, 7, 8, 9, 11 showed higher anti-tubercular activity and compounds 7, 8, 10, 11, 12 have proved to be effective with MIC (μg/ml) and emerged as lead molecules showing excellent activities against a panel of microorganisms. All synthesized compounds were characterized using IR, 1H, 13C NMR, GC–MS and elemental analysis.
An efficient synthetic protocol for condensation of 5-(nitro/bromo)-o-phenylenediamine with trans-cinnamic acids to prepare novel 5-(nitro/bromo)-styryl-2-benzimidazole is obtained. The characterized compounds were screened for their in vitro anti-tubercular, anti-microbial and antifungal activities.Figure optionsDownload as PowerPoint slide
Journal: European Journal of Medicinal Chemistry - Volume 44, Issue 10, October 2009, Pages 4244–4248